array:24 ["pii" => "S2173579424000720" "issn" => "21735794" "doi" => "10.1016/j.oftale.2024.04.010" "estado" => "S300" "fechaPublicacion" => "2024-08-01" "aid" => "2225" "copyright" => "Sociedad Española de Oftalmología" "copyrightAnyo" => "2024" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Arch Soc Esp Oftalmol. 2024;99:344-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0365669124000467" "issn" => "03656691" "doi" => "10.1016/j.oftal.2024.03.003" "estado" => "S300" "fechaPublicacion" => "2024-08-01" "aid" => "2225" "copyright" => "Sociedad Española de Oftalmología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Arch Soc Esp Oftalmol. 2024;99:344-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "Comunicación corta" "titulo" => "Presunta maculopatía bilateral asociada a fluoxetina" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "344" "paginaFinal" => "346" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Presumed fluoxetine maculopathy" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0015" "etiqueta" => "Figura 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 735 "Ancho" => 2007 "Tamanyo" => 215467 ] ] "descripcion" => array:1 [ "es" => "A) OCT macular: alteración de la elipsoides con disrupción de esta capa en ambos ojos. B)OCT macular: se observa una mejoría progresiva de la reorganización de las capas externas de la retina en ambos ojos." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "N. Moreno Benito, P.B. Blasco Palacio, I. Rodríguez García" "autores" => array:3 [ 0 => array:2 [ "nombre" => "N." "apellidos" => "Moreno Benito" ] 1 => array:2 [ "nombre" => "P.B." "apellidos" => "Blasco Palacio" ] 2 => array:2 [ "nombre" => "I." "apellidos" => "Rodríguez García" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173579424000720" "doi" => "10.1016/j.oftale.2024.04.010" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173579424000720?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365669124000467?idApp=UINPBA00004N" "url" => "/03656691/0000009900000008/v1_202408010629/S0365669124000467/v1_202408010629/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2173579424000781" "issn" => "21735794" "doi" => "10.1016/j.oftale.2024.05.002" "estado" => "S300" "fechaPublicacion" => "2024-08-01" "aid" => "2233" "copyright" => "Sociedad Española de Oftalmología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Arch Soc Esp Oftalmol. 2024;99:347-51" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "Short communication" "titulo" => "Diagnostic and therapeutic complexity of Susac syndrome" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "347" "paginaFinal" => "351" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Complejidad diagnóstica y terapéutica del síndrome de Susac" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0015" "etiqueta" => "Fig. 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 3960 "Ancho" => 3017 "Tamanyo" => 1719646 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0015" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Above, right eye; below, left eye. (A) Fundus photograph. (B) Fluorescein angiography. (C) Optical coherence tomography angiography of the superficial and deep plexus showing correlation of areas of ischemia with angiographic occlusions. (D) Visual field alterations." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "V.A. Fierro-Rosales, L. de Juan-Marcos, A. Bermúdez-Cortés, R. Lorenzo-Pérez, P.M. Serafim-Reis" "autores" => array:5 [ 0 => array:2 [ "nombre" => "V.A." "apellidos" => "Fierro-Rosales" ] 1 => array:2 [ "nombre" => "L." "apellidos" => "de Juan-Marcos" ] 2 => array:2 [ "nombre" => "A." "apellidos" => "Bermúdez-Cortés" ] 3 => array:2 [ "nombre" => "R." "apellidos" => "Lorenzo-Pérez" ] 4 => array:2 [ "nombre" => "P.M." "apellidos" => "Serafim-Reis" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0365669124000613" "doi" => "10.1016/j.oftal.2024.03.011" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365669124000613?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173579424000781?idApp=UINPBA00004N" "url" => "/21735794/0000009900000008/v1_202408010614/S2173579424000781/v1_202408010614/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2173579424000549" "issn" => "21735794" "doi" => "10.1016/j.oftale.2024.04.002" "estado" => "S300" "fechaPublicacion" => "2024-08-01" "aid" => "2223" "copyright" => "Sociedad Española de Oftalmología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Arch Soc Esp Oftalmol. 2024;99:340-3" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "Short communication" "titulo" => "Cicatrizing keratoconjunctivitis secondary to ocular lichen planus: A case report" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "340" "paginaFinal" => "343" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Queratoconjuntivitis mucosinequiante secundaria a liquen plano ocular: a propósito de un caso" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 456 "Ancho" => 605 "Tamanyo" => 85324 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0010" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Skin biopsy showing some irregular hyperplasia of the epidermis with necrotic keratinocytes (Civatte bodies) and vacuolar degeneration of the basal layer, as well as the presence of an inflammatory infiltrate consisting of lymphocytes and melanophages in the underlying dermis." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Chamorro González-Cuevas, V. Antón Modrego, B. García-Valcárcel González" "autores" => array:3 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Chamorro González-Cuevas" ] 1 => array:2 [ "nombre" => "V." "apellidos" => "Antón Modrego" ] 2 => array:2 [ "nombre" => "B." "apellidos" => "García-Valcárcel González" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0365669124000443" "doi" => "10.1016/j.oftal.2024.03.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365669124000443?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173579424000549?idApp=UINPBA00004N" "url" => "/21735794/0000009900000008/v1_202408010614/S2173579424000549/v1_202408010614/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "Short communication" "titulo" => "Presumed fluoxetine maculopathy" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "344" "paginaFinal" => "346" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "N. Moreno Benito, P.B. Blasco Palacio, I. Rodríguez García" "autores" => array:3 [ 0 => array:2 [ "nombre" => "N." "apellidos" => "Moreno Benito" ] 1 => array:4 [ "nombre" => "P.B." "apellidos" => "Blasco Palacio" "email" => array:1 [ 0 => "polblascozaragoza@hotmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 2 => array:2 [ "nombre" => "I." "apellidos" => "Rodríguez García" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio Oftalmología, Hospital de Basurto, Bilbao, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Presunta maculopatía bilateral asociada a fluoxetina" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0015" "etiqueta" => "Fig. 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 735 "Ancho" => 2007 "Tamanyo" => 215467 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0015" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "(A) Macular OCT: alteration of the ellipsoid with disruption of this layer in both eyes. (B) Macular OCT: progressive enhancement of the reorganization of the outer retinal layers in both eyes." ] ] ] "textoCompleto" => "IntroductionThe prescription of antidepressants has increased considerably in the last decade, with a preference for more current antidepressants, such as selective serotonin reuptake inhibitors (SSRIs).The ocular adverse effects described with SSRIs are: dry eye, decreased accommodation and blurred vision (especially when taking paroxetine), mydriasis, acute glaucoma due to angle closure, optic neuropathy and maculopathy (described when taking sertraline).<a class="elsevierStyleCrossRef" href="#bib0005">1</a> No cases of maculopathy have been published to date for fluoxetine, although it shares the same mechanism of action as sertraline.Case presentationMale, 49, Caucasian, diagnosed with obsessive-compulsive disorder (OCD) who was prescribed 10 mg of fluoxetine (Prozac® ) by his psychiatrist. Fifteen days from the start of treatment he reported visual symptoms, exhibiting decreased distant visual acuity, difficulty in focusing, central scotoma in the left eye (LE), mydriasis in both eyes (BE) and decreased color saturation. The patient took the medication for 3 months, visual symptoms persisted and decided to abandon the treatment. Within 5 days of stopping treatment he began noticing improvement in symptoms.One month later, the patient attended ophthalmology consultations and underwent the following visual examination: VA BE 1.0 with correction, Goldman IOP tonometer 16/18 mmHg, anterior pole without relevant findings, normoreactive isochoric pupils, contact gonioscopy showed open angle grade IV, and in BE fundus there was a change in macular coloration (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). As for complementary tests, Ishihara 17/17 test was performed without alterations, optical coherence tomography (OCT) Heidelberg Spectralis CFNr without alterations, OCT CG without alterations, FAF-blue Heidelberg Spectralis without alterations (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>), CV 24-2 Sita Fast Humphrey Visual Field testing showed no scotomas or other type of alteration and VEP within normal limits, highlighting in the macular OCT alteration of the ellipsoid in BE with disruption of this layer (<a class="elsevierStyleCrossRef" href="#fig0015">Fig. 3</a>A). In the follow-up visits, macular OCT was performed, showing a progressive improvement of the reorganization of the outer retinal layers in BE (<a class="elsevierStyleCrossRef" href="#fig0015">Fig. 3</a>B).<elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="fig0010"></elsevierMultimedia><elsevierMultimedia ident="fig0015"></elsevierMultimedia>Regarding patient history, he was in psychiatric treatment for OCD with quetiapine 150 mg every 24 h, lormetazepam 2 mg every 24 h and had recently started fluoxetine 10 mg every 24 h. He does not present other diseases or take other treatments. Given the macular OCT findings, we questioned the patient several times about taking Popper, sildenafil and similar substances, which the patient denied. We also questioned about sunlight intake, and the patient admitted to having sunbathed in the summer months with filter 2 goggle protection, but without prolonged or direct exposure. In addition, we did not observe vitreomacular traction on OCT that could cause lesions similar to those present in this case. No cases of maculopathy have been reported with quetiapine or lormetazepam or similar drugs of the same family.DiscussionTo date, this is the only published case of maculopathy caused by fluoxetine that we are aware of. At present there are 8 published cases of sertraline-induced maculopathy,<a class="elsevierStyleCrossRefs" href="#bib0010">2–4</a> 3 of them recently published in a case series.<a class="elsevierStyleCrossRef" href="#bib0010">2</a> The changes found in the macular OCT of the present case are almost identical to those reported in the sertraline maculopathy cases by Javidi et al.<a class="elsevierStyleCrossRef" href="#bib0010">2</a> The latter, together with the fact that sertraline and fluoxetine share the same mechanism of action, suggests that we may be dealing with maculopathy caused by SSRIs. In June 2019, the European Medicines Agency (EMA) added new adverse reactions of sertraline: maculopathy, vision of spots in front of the eyes, irregular pupils, visual disturbances and partial loss of vision, among others.<a class="elsevierStyleCrossRef" href="#bib0025">5</a>In view of the unusual case, possible pathologies presenting the same characteristics were ruled out in the OCT, which were phototoxicity, taking Popper, taking sildenafil and similar, and, finally, vitreomacular traction. The OCT ruled out this last option, and in the exhaustive anamnesis performed on the patient, he denied the intake of the aforementioned substances and prolonged exposure to laser or unprotected sunlight.Although more case series and research are needed to ensure that both sertraline and fluoxetine can cause maculopathy, the temporal sequence of events and the subjective and objective improvement of the lesions after cessation of treatment indicate that they are a likely cause. Therefore, health care professionals should be attentive to ophthalmological symptoms for which patients treated with SSRIs consult and even ask about their appearance during follow-up visits. The case presented has been reported to the Spanish Agency of Medicines and Health Products (AEMPS).Conflict of interestNo conflicts of interest were declared by the authors.Informed consentThe authors have obtained informed consent for the publication of the images." "textoCompletoSecciones" => array:1 [ "secciones" => array:10 [ 0 => array:3 [ "identificador" => "xres2214466" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0005" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1856569" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres2214465" "titulo" => "Resumen" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0010" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec1856570" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Case presentation" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "Discussion" ] 7 => array:2 [ "identificador" => "sec0020" "titulo" => "Conflict of interest" ] 8 => array:2 [ "identificador" => "sec0025" "titulo" => "Informed consent" ] 9 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2024-01-19" "fechaAceptado" => "2024-03-02" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1856569" "palabras" => array:6 [ 0 => "Fluoxetine" 1 => "Maculopathy" 2 => "Disruption" 3 => "SSRIs" 4 => "OCT" 5 => "Outer retinal layer" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec1856570" "palabras" => array:6 [ 0 => "Fluoxetina" 1 => "Maculopatía" 2 => "Disrupción" 3 => "ISRS" 4 => "OCT" 5 => "Capas externas de la retina" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "To report a unique case of a patient who developed simultaneous bilateral maculopathy presumed from intake of fluoxetine. The optic coherence tomography (OCT) macular showed a subfoveal disruption in the outer retinal layer in both eyes (OU), higher in the left one (OS). Although reported cases of serotonin recapture inhibitors (SSRIs) Maculopathy so far have been caused by sertraline, fluoxetine shares the biological mechanism, and OCT findings and ocular symptoms are the same as published. We should be aware with ocular symptoms in patients that take fluoxetine." ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "Presentamos el caso único de un paciente con maculopatía bilateral tras la toma de fluoxetina. En la tomografía de coherencia óptica (OCT) macular se observa una disrupción en la capa de elipsoides a nivel subfoveal en ambos ojos (AO), mayor en ojo izquierdo (OI). Aunque los casos reportados de maculopatía por Inhibidores de la recaptación de serotonina (ISRS) hasta ahora han sido causados por sertralina, la fluoxetina comparte el mismo mecanismo de acción y los hallazgos en la OCT macular del paciente presentado y sus síntomas coinciden con los publicados en los casos de maculopatía por sertralina. Por ello debemos estar atentos a los síntomas oftalmológicos que pudieran tener los pacientes que están en tratamiento con fluoxetina y realizarles una exploración oftalmológica." ] ] "multimedia" => array:3 [ 0 => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 377 "Ancho" => 755 "Tamanyo" => 50646 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Macular coloration changes." ] ] 1 => array:8 [ "identificador" => "fig0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 373 "Ancho" => 755 "Tamanyo" => 61247 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0010" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "FAF autofluorescence Heidelberg Spectralis without alterations." ] ] 2 => array:8 [ "identificador" => "fig0015" "etiqueta" => "Fig. 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 735 "Ancho" => 2007 "Tamanyo" => 215467 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0015" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "(A) Macular OCT: alteration of the ellipsoid with disruption of this layer in both eyes. (B) Macular OCT: progressive enhancement of the reorganization of the outer retinal layers in both eyes." ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ocular adverse effects of antidepressants – Need for an ophthalmic screening and follow up protocol" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "V. Narayanan" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ophthalmol Res Int J" "fecha" => "2019" "volumen" => "10" "numero" => "3" "paginaInicial" => "1" "paginaFinal" => "6" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Presumed sertraline-associated maculopathy: a case report" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "H. Javidi" 1 => "S. Ah-Moye" 2 => "C. Hennings" 3 => "H. Mehta" 4 => "S. Mahmood" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s40123-021-00340-7" "Revista" => array:2 [ "tituloSerie" => "Ophthalmol Ther." "fecha" => "2021" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bull’s eye maculopathy in a patient taking sertraline" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J.O. Mason 3rd" 1 => "S.A. Patel" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/ICB.0000000000000115" "Revista" => array:7 [ "tituloSerie" => "Retin Cases Brief Rep" "fecha" => "2015" "volumen" => "9" "numero" => "2" "paginaInicial" => "131" "paginaFinal" => "133" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25401995" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bilateral maculopathy associated with sertraline" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S.Y. Ewe" 1 => "R.G. Abell" 2 => "B.J. Vote" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/1039856214556327" "Revista" => array:7 [ "tituloSerie" => "Australas Psychiatry." "fecha" => "2014" "volumen" => "22" "numero" => "6" "paginaInicial" => "573" "paginaFinal" => "575" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25358654" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Recomendaciones del PRAC sobre. señales: nuevo texto de información sobre el producto adoptadas por el PRAC el 13-16 de mayo de 2019. 11 June 2019 EMA/PRAC/286522/2019 Pharmacovigilance Risk Assessment Committee (PRAC). Sertralina – Maculopatía (EPITT n.º 19 341)." ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735794/0000009900000008/v1_202408010614/S2173579424000720/v1_202408010614/en/main.assets" "Apartado" => array:4 [ "identificador" => "5812" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Short communications" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735794/0000009900000008/v1_202408010614/S2173579424000720/v1_202408010614/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173579424000720?idApp=UINPBA00004N"]

ISSN: 2173-5794
e-ISSN: 1989-7286

Archivos de la Sociedad Española de Oftalmología is the official journal of the Ophthalmology Society of Spain, that has over 4,000 members. It gives priority to the publication of basic, translational and clinic research including reviews, original articles, short communications, editorials, letters to the editor and clinic practice guides related to Ophthalmology and its subspecialties. A small section of the journal is reserved for the most relevant papers presented at the annual Congress of the Society. All manuscripts considered for publication are reviewed by expert examiner peers (double blind). The journal is published monthly and even though its official language is Spanish all articles are translated into English to increase the dissemination of scientific information. At present, Archivos is the only Spanish language Ophthalmology journal indexed in PubMed/MEDLINE in addition to other prestigious international databases such as Scopus.

See more Open Access Option

Indexed in:

PubMed/MedLine, Scopus, EMBASE, IBECS, IME, SCIELO, BIOSIS, SENIOR, COMPLUDOC

Subscribe:

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

1.2

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.247

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.263

View more metrics

Journal Information

Previous article | Next article

Lee este artículo en Español

Export reference

Download PDF

Purchase article

For the purchase of this article it is necessary to fill in the following form:

Name *

First surname *

Second surname

Email *

Address *

Number *

City *

Afganistan

Albania

Alemania

Andorra

Angola

Anguilla

Antartica

Antigua and barbuda

Antillas holandesas

Arabia saudita

Argelia

Argentina

Armenia

Aruba

Australia

Austria

Azerbaijan

Bahamas

Bahrain

Bangladesh

Barbados

Belarus

Belgica

Belice

Benin

Bermudas/antillas britanicas

Bhutan

Bolivia

Bosnia y herzegowina

Botswana

Brasil

Brunei darussalam

Bulgaria

Burkina faso

Burundi

Cabo verde

Camboya

Camerun

Canada

Chad

Chile

China

Chipre

Colombia

Comoros

Corea

Costa rica

Cote d´ivoire

Croacia

Cuba

Dinamarca

Djibouti

Dominica

East timor

Ecuador

Egipto

El salvador

Emiratos arabes unidos

Eritrea

Escocia

Eslovaquia

Eslovenia

España

Estados federados de micronesia

Estados unidos

Estonia

Etiopia

Fiji

Filipinas

Finlandia

Francia

Gabon

Gambia

Georgia

Ghana

Gibraltar

Grecia

Grenada

Groenlandia

Guadalupe

Guam

Guatemala

Guayana britanica

Guinea

Guinea ecuatorial

Guinea francesa

Guinea-bissau

Haiti

Holanda

Honduras

Hong kong

Hungria

India

Indonesia

Irak

Iran

Irlanda

Isla bouvet

Isla cocos (keeling)

Isla cook

Isla mauricio

Isla navidad

Isla norfolk

Islandia

Islas caiman

Islas falkland (malvinas)

Islas faroe

Islas georgia del sur y sandwich

Islas heard and mc donald

Islas marshall

Islas northern mariana

Islas salomon

Islas svalbard and jan mayen

Islas turks and caicos

Islas united states minor outlyi

Islas virgenes (britanicas)

Islas virgenes (u.s.a.)

Islas wallis and futuna

Israel

Italia

Jamaica

Japon

Jordania

Kazakhstan

Kenia

Kiribati

Kuwait

Kyrgyzstan

Lesoto

Letonia

Libano

Liberia

Libia arab jamahiriya

Liechtenstein

Lituania

Luxemburgo

Macao

Macedonia

Madagascar

Malasia

Malawi

Maldives

Mali

Malta

Marruecos

Martinica

Mauritania

Mayotte

Mexico

Monaco

Mongolia

Monserrat

Morocco

Mozambique

Myanmar

Namibia

Nauru

Nepal

Nicaragua

Niger

Nigeria

Niue

Noruega

Nueva caledonia

Nueva zelanda

Oman

Pakistan

Palau

Panama

Papua new guinea

Paraguay

Peru

Pitcairn

Polinesia francesa

Polonia

Portugal

Posesiones gran bretaña

Posesiones u.s.a.

Puerto rico

Qatar

Reino unido

Republica checa

Republica de africa central

Republica de cabo verde

Republica de congo

Republica de corea

Republica de moldova

Republica democratica de laos

Republica democratica del congo

Republica dominicana

Reunion

Ruanda

Rumania

Rusia

Sahara occidental

Saint kitts and nevis

Samoa

Samoa americana

San marino

San tomas y principe

San vincent and the grenadines

Santa lucia

Senegal

Serbia

Seychelles

Sierra leona

Singapur

Siria

Somalia

Sri lanka

St. helena

St. pierre and miquelon

Sudafrica

Sudan

Suecia

Suiza

Surinam

Swaziland

Tailandia

Taiwan republica de china

Tajikistan

Tanzania

Territorio de indias britanicas

Togo

Tokelau

Tonga

Trinidad and tobago

Tunisia

Turkmenistan

Turquia

Tuvalu

Ucrania

Uganda

Uruguay

Uzbekistan

Vanuatu

Vaticano

Venezuela

Vietnam

Yemen

Yugoslavia

Zambia

Zimbawe

Lebanon

Paises bajos

A coruña

Alava

Albacete

Alicante

Almeria

Asturias

Avila

Badajoz

Balears

Barcelona

Bizkaia

Burgos

Caceres

Cadiz

Cantabria

Castellon

Ceuta

Ciudad real

Cordoba

Cuenca

Girona

Granada

Guadalajara

Guipuzcoa

Huelva

Huesca

Jaen

La rioja

Las palmas

Leon

Lleida

Lugo

Madrid

Malaga

Melilla

Murcia

Navarra

Ourense

Palencia

Pontevedra

Salamanca

Segovia

Sevilla

Soria

Tarragona

Tenerife

Teruel

Toledo

Valencia

Valladolid

Zamora

Zaragoza

-- Not applicable --

Código postal *

Phone *

NIF o número identificativo *

I accept to receive information about Elsevier's special products and promotions by email

I accept to receive information about products and special promotions from Elsevier partners by email

I have read and understand the Privacy Policy and Terms and conditions and agree to be bound by all of its terms.

* Required fields

Además del acceso temporal al artículo, este le será enviado por correo electrónico.

Atención al cliente

Phone

Llamadas desde España

932 415 960

Llamadas desde el extranjero

+34 932 415 960

Horario de 9 a 18h. excepto los meses de julio y agosto que será de 9 a 15h.

Publish in

Archivos de la Sociedad Española de Oftalmología

Archivos de la Sociedad Española de Oftalmología (English Edition) is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.

Free access articles

Training in cataract surgery in Spain: analysis of the...

Arch Soc Esp Oftalmol. 2024;99:373-82

Approaches to the epidemiology of NOHL in the region of...

Arch Soc Esp Oftalmol. 2023;98:673-9

Indexed in:

Follow us:

Subscribe:

Purchase article

Subscribe to our newsletter